TD Cowen analyst Ken Cacciatore maintains Takeda Pharmaceutical (NYSE:TAK) with a Outperform and lowers the price target from $30 to $20.
- Headlines
- TD Cowen Maintains Outperform on Takeda Pharmaceutical, Lowers Price Target to $20
TD Cowen Maintains Outperform on Takeda Pharmaceutical, Lowers Price Target to $20
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
10:18
Shanghai further strengthens the management of distributed photovoltaic projects.
10:17
Is it likely to become a strategic reserve? Bitcoin once broke through $0.106 million.
Bitcoin+0.53%
10:17
National Bureau of Statistics: Imports and exports of goods continue to grow, and the trade structure continues to optimize.